Koninklijke Philips reported EUR4.51B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Danaher USD 6.3B 350M Jun/2026
Demant DKK 6.25B 800M Dec/2025
Dexcom USD 1.31B 120M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Fresenius EUR 5.95B 210M Jun/2026
General Electric Aerospace USD 12.63B 1.03B Jun/2026
Getinge SEK 8.38B 1000K Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
GN Store Nord DKK 3.85B 830M Mar/2026
Hitachi JPY 2.71T 370B Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
Intuitive Surgical USD 2.89B 120M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Koninklijke Philips EUR 4.51B 1.42B Mar/2026
Medtronic USD 9.8B 800M Mar/2026
Philips EUR 4.36B 450M Jun/2026
ResMed USD 1.46B 60M Jun/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026
Steris USD 1.5B 90M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Terumo JPY 311.81B 11.49B Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026